Back to all articles
•Technology

Navigating Medtech Challenges: Insights from BioticsAI's Path to FDA Approval

View original source

The latest episode of Build Mode features an in-depth conversation between Isabelle Johannessen and Robhy Bustami, the co-founder and CEO of BioticsAI, a company creating an AI copilot for ultrasound to help detect fetal abnormalities. This startup, which emerged successful from Startup Battlefield, has traversed the lengthy and stringent path to FDA approval.

  • Key Discussion Points:
    • The complexities of keeping a team motivated when facing uncertainties in securing FDA approval.
    • Essential insights for founders on navigating the FDA approval process.
    • The importance of aligning with investors who comprehend the slow, high-risk nature of the medtech industry.
    • The critical role of cross-functional teamwork among engineers, clinicians, and researchers.
    • The significance of relying on active industry expert advisors over big names.
    • Strategies for maintaining momentum and celebrating milestones throughout prolonged and uncertain timelines.